1.

The Outcome and Safety of Re-challenge Lutetium-177 PSMA (177Lu-PSMA) Therapy with Low-Dose Docetaxel as a Radiosensitizer-a Promising Combination in Metastatic Castrate-Resistant Prostate Cancer (mCRPC): a Case Report.

Maharaj M, Heslop L, Govender T, Korowlay N, Singh A, Choudhary P, Sathekge M.

Nucl Med Mol Imaging. 2021 Jun;55(3):136-140. doi: 10.1007/s13139-021-00696-5. Epub 2021 Apr 13.

PMID: 34093893

2.

Radionuclide Imaging of Fungal Infections and Correlation with the Host Defense Response.

Ankrah AO, Sathekge MM, Dierckx RAJO, Glaudemans AWJM.

J Fungi (Basel). 2021 May 22;7(6):407. doi: 10.3390/jof7060407.

PMID: 34067410Review.

3.

68Ga-FAPI-PET/CT in patients with various gynecological malignancies.

Dendl K, Koerber SA, Finck R, Mokoala KMG, Staudinger F, Schillings L, Heger U, Röhrich M, Kratochwil C, Sathekge M, Jäger D, Debus J, Haberkorn U, Giesel FL.

Eur J Nucl Med Mol Imaging. 2021 May 29. doi: 10.1007/s00259-021-05378-0. Online ahead of print.

PMID: 34050777

4.

The impact of the extent of the bone involvement on overall survival and toxicity in mCRPC patients receiving [177Lu]Lu-PSMA-617: a WARMTH multicentre study.

Ahmadzadehfar H, Matern R, Baum RP, Seifert R, Kessel K, Bögemann M, Kratochwil C, Rathke H, Ilhan H, Svirydenka H, Sathekge M, Kabasakal L, Yordanova A, Garcia-Perez FO, Kairemo K, Maharaj M, Paez D, Virgolini I, Rahbar K.

Eur J Nucl Med Mol Imaging. 2021 May 25. doi: 10.1007/s00259-021-05383-3. Online ahead of print.

PMID: 34031719

5.

Letter from the Editors.

Bouchelouche K, Sathekge MM.

Semin Nucl Med. 2021 Jul;51(4):309-311. doi: 10.1053/j.semnuclmed.2021.01.005.

PMID: 34016291Free PMC article.No abstract available.

6.

Immune Checkpoints, Inhibitors and Radionuclides in Prostate Cancer: Promising Combinatorial Therapy Approach.

Kgatle MM, Boshomane TMG, Lawal IO, Mokoala KMG, Mokgoro NP, Lourens N, Kairemo K, Zeevaart JR, Vorster M, Sathekge MM.

Int J Mol Sci. 2021 Apr 15;22(8):4109. doi: 10.3390/ijms22084109.

PMID: 33921181Free PMC article.Review.

7.

Adjunctive Use of Statins for COVID-19.

Sathekge M, Byttebier G, De Spiegeleer B, Saxberg B, Ueckermann V, Belmans L, Alexander M, Fedson D.

J Clin Med. 2021 Apr 1;10(7):1407. doi: 10.3390/jcm10071407.

PMID: 33915784Free PMC article.

8.

Apoptosis Imaging in Oncology by Means of Positron Emission Tomography: A Review.

Van de Wiele C, Ustmert S, De Spiegeleer B, De Jonghe PJ, Sathekge M, Alex M.

Int J Mol Sci. 2021 Mar 9;22(5):2753. doi: 10.3390/ijms22052753.

PMID: 33803180Free PMC article.Review.

9.

Letter from the Editors.

Sathekge MM, Bouchelouche K.

Semin Nucl Med. 2021 May;51(3):193-195. doi: 10.1053/j.semnuclmed.2021.01.004.

PMID: 33745660No abstract available.

10.

Coronavirus (COVID-19) pandemic mediated changing trends in nuclear medicine education and training: time to change and scintillate.

Gnanasegaran G, Paez D, Sathekge M, Giammarile F, Fanti S, Chiti A, Bom H, Vinjamuri S, Pascual TN, Bomanji J.

Eur J Nucl Med Mol Imaging. 2021 Mar 4:1-9. doi: 10.1007/s00259-021-05241-2. Online ahead of print.

PMID: 33661327Free PMC article.No abstract available.

11.

Correction to: Non-oncological applications of RGD-based single-photon emission tomography and positron emission tomography agents.

Ebenhan T, Kleynhans J, Zeevaart JR, Jeong JM, Sathekge M.

Eur J Nucl Med Mol Imaging. 2021 May;48(5):1695. doi: 10.1007/s00259-021-05264-9.

PMID: 33660101No abstract available.

12.

The Association of Tumor Burden by 18F-FDG PET/CT and Survival in Vulvar Carcinoma.

Mokoala KMG, Lawal IO, Lengana T, Popoola GO, Boshomane TMG, Mokgoro NP, Vorster M, Sathekge MM.

Clin Nucl Med. 2021 May 1;46(5):375-381. doi: 10.1097/RLU.0000000000003549.

PMID: 33630802

13.

Letter from the Editors.

Bouchelouche K, Sathekge MM.

Semin Nucl Med. 2021 Mar;51(2):99-101. doi: 10.1053/j.semnuclmed.2020.11.001.

PMID: 33509375No abstract available.

14.

The Added Value of [18F]FDG PET/CT in the Management of Invasive Fungal Infections.

Ankrah AO, Creemers-Schild D, de Keizer B, Klein HC, Dierckx RAJO, Kwee TC, Span LFR, de Jong PA, Sathekge MM, Glaudemans AWJM.

Diagnostics (Basel). 2021 Jan 17;11(1):137. doi: 10.3390/diagnostics11010137.

PMID: 33477267Free PMC article.

15.

An overview of the developments and potential applications of 68Ga-labelled PET/CT hypoxia imaging.

Bresser PL, Vorster M, Sathekge MM.

Ann Nucl Med. 2021 Feb;35(2):148-158. doi: 10.1007/s12149-020-01563-7. Epub 2021 Jan 5.

PMID: 33400147Review.

16.

Diagnostic value of sentinel lymph node scintigraphy and 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in the detection of metastatic lymph nodes in patients with early-stage cervical cancer.

Reyneke F, Snyman LC, Lawal I, Lengana T, Vorster M, Sathekge M.

World J Nucl Med. 2020 Jul 22;19(3):240-245. doi: 10.4103/wjnm.WJNM_74_19. eCollection 2020 Jul-Sep.

PMID: 33354179Free PMC article.

17.

[68Ga]Ga-Pentixafor for PET Imaging of Vascular Expression of CXCR-4 as a Marker of Arterial Inflammation in HIV-Infected Patients: A Comparison with 18F[FDG] PET Imaging.

Lawal IO, Popoola GO, Mahapane J, Kaufmann J, Davis C, Ndlovu H, Maserumule LC, Mokoala KMG, Bouterfa H, Wester HJ, Zeevaart JR, Sathekge MM.

Biomolecules. 2020 Dec 3;10(12):1629. doi: 10.3390/biom10121629.

PMID: 33287237Free PMC article.

18.

FDG PET/CT for evaluating systemic arterial inflammation induced by anthracycline-based chemotherapy of Hodgkin lymphoma: A retrospective cohort study.

Lawal IO, Orunmuyi AT, Popoola GO, Lengana T, Mokoala KMG, Ankrah AO, Sathekge MM.

Medicine (Baltimore). 2020 Nov 25;99(48):e23259. doi: 10.1097/MD.0000000000023259.

PMID: 33235083Free PMC article.

19.

Comparison of MRI, [18F]FDG PET/CT, and 99mTc-UBI 29-41 scintigraphy for postoperative spondylodiscitis-a prospective multicenter study.

Paez D, Sathekge MM, Douis H, Giammarile F, Fatima S, Dhal A, Puri SK, Erba PA, Lazzeri E, Ferrando R, Filho PA, Magboo VP, Morozova O, Núñez R, Pellet O, Mariani G.

Eur J Nucl Med Mol Imaging. 2021 Jun;48(6):1864-1875. doi: 10.1007/s00259-020-05109-x. Epub 2020 Nov 18.

PMID: 33210240Free PMC article.

20.

Letter from the Editors.

Bouchelouche K, Sathekge MM.

Semin Nucl Med. 2020 Nov;50(6):485-487. doi: 10.1053/j.semnuclmed.2020.07.011.

PMID: 33059818No abstract available.

21.

Underutilisation of nuclear medicine scans at a regional hospital in Nigeria: need for implementation research.

Orunmuyi AT, Lawal IO, Omofuma OO, Taiwo OJ, Sathekge MM.

Ecancermedicalscience. 2020 Aug 28;14:1093. doi: 10.3332/ecancer.2020.1093. eCollection 2020.

PMID: 33014135Free PMC article.

22.

Non-oncological applications of RGD-based single-photon emission tomography and positron emission tomography agents.

Ebenhan T, Kleynhans J, Zeevaart JR, Jeong JM, Sathekge M.

Eur J Nucl Med Mol Imaging. 2021 May;48(5):1414-1433. doi: 10.1007/s00259-020-04975-9. Epub 2020 Sep 12.

PMID: 32918574Review.

23.

18F-FDG PET/CT imaging of vulva cancer recurrence: A comparison of PET-derived metabolic parameters between women with and without HIV infection.

Mokoala KMG, Lawal IO, Lengana T, Popoola GO, Boshomane TMG, Mokgoro NP, Vorster M, Sathekge MM.

Nuklearmedizin. 2020 Dec;59(6):419-427. doi: 10.1055/a-1221-7810. Epub 2020 Sep 1.

PMID: 32871597English.

24.

Characterization of FDG PET Images Using Texture Analysis in Tumors of the Gastro-Intestinal Tract: A Review.

Deleu AL, Sathekge MJ, Maes A, De Spiegeleer B, Sathekge M, Van de Wiele C.

Biomedicines. 2020 Aug 24;8(9):304. doi: 10.3390/biomedicines8090304.

PMID: 32846986Free PMC article.Review.

25.

Letter from the Editors.

Sathekge MM, Bouchelouche K.

Semin Nucl Med. 2020 Sep;50(5):387-388. doi: 10.1053/j.semnuclmed.2020.06.004.

PMID: 32768002No abstract available.

26.

Imaging Bacteria with Radiolabelled Probes: Is It Feasible?

Signore A, Artiko V, Conserva M, Ferro-Flores G, Welling MM, Jain SK, Hess S, Sathekge M.

J Clin Med. 2020 Jul 25;9(8):2372. doi: 10.3390/jcm9082372.

PMID: 32722355Free PMC article.

27.

Single Photon Emission Tomography in the Diagnostic Assessment of Cardiac and Vascular Infectious Diseases.

Lawal IO, Kleyhans J, Mokoala KMG, Vorster M, Ebenhan T, Zeevaart JR, Sathekge MM.

Curr Radiopharm. 2020 Jun 21. doi: 10.2174/1874471013666200621190001. Online ahead of print.

PMID: 32564768

28.

Letter from the Editors.

Bouchelouche K, Sathekge MM.

Semin Nucl Med. 2020 Jul;50(4):281-282. doi: 10.1053/j.semnuclmed.2020.03.006. Epub 2020 Apr 22.

PMID: 32540025No abstract available.

29.

Sequential 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) scan findings in patients with extrapulmonary tuberculosis during the course of treatment-a prospective observational study.

Bomanji J, Sharma R, Mittal BR, Gambhir S, Qureshy A, Begum SMF, Paez D, Sathekge M, Vorster M, Sobic Saranovic D, Pusuwan P, Mann V, Vinjamuri S, Zumla A, Pascual TNB.

Eur J Nucl Med Mol Imaging. 2020 Dec;47(13):3118-3129. doi: 10.1007/s00259-020-04888-7. Epub 2020 Jun 2.

PMID: 32483653

30.

Correction to: Nuclear medicine services after COVID-19: gearing up back to normality.

Huang HL, Gnanasegaran G, Paez D, Fanti S, Hacker M, Sathekge M, Bom HS, Cerci JJ, Chiti A, Lan X, Herrmann K, Scott AM, Vinjamuri S, Dorbala S, Estrada E, Pellet O, Orellana P, El-Haj N, Giammarile F, Abdel-Wahab M, Bomanji J.

Eur J Nucl Med Mol Imaging. 2020 Aug;47(9):2220. doi: 10.1007/s00259-020-04884-x.

PMID: 32462399Free PMC article.

31.

A prospective intra-individual comparison of [68Ga]Ga-PSMA-11 PET/CT, [68Ga]Ga-NODAGAZOL PET/CT, and [99mTc]Tc-MDP bone scintigraphy for radionuclide imaging of prostate cancer skeletal metastases.

Lawal IO, Mokoala KMG, Mahapane J, Kleyhans J, Meckel M, Vorster M, Ebenhan T, Rösch F, Sathekge MM.

Eur J Nucl Med Mol Imaging. 2021 Jan;48(1):134-142. doi: 10.1007/s00259-020-04867-y. Epub 2020 May 18.

PMID: 32424485

32.

Prior therapies as prognostic factors of overall survival in metastatic castration-resistant prostate cancer patients treated with [177Lu]Lu-PSMA-617. A WARMTH multicenter study (the 617 trial).

Ahmadzadehfar H, Rahbar K, Baum RP, Seifert R, Kessel K, Bögemann M, Kulkarni HR, Zhang J, Gerke C, Fimmers R, Kratochwil C, Rathke H, Ilhan H, Maffey-Steffan J, Sathekge M, Kabasakal L, Garcia-Perez FO, Kairemo K, Maharaj M, Paez D, Virgolini I.

Eur J Nucl Med Mol Imaging. 2021 Jan;48(1):113-122. doi: 10.1007/s00259-020-04797-9. Epub 2020 May 8.

PMID: 32383093Free PMC article.

33.

Nuclear medicine services after COVID-19: gearing up back to normality.

Huang HL, Gnanasegaran G, Paez D, Fanti S, Hacker M, Sathekge M, Bom HS, Cerci JJ, Chiti A, Lan X, Herrmann K, Scott AM, Vinjamuri S, Dorbala S, Estrada E, Pellet O, Orellana P, El-Haj N, Giammarile F, Abdel-Wahab M, Bomanji J.

Eur J Nucl Med Mol Imaging. 2020 Aug;47(9):2048-2053. doi: 10.1007/s00259-020-04848-1.

PMID: 32367256Free PMC article.No abstract available.

34.

COVID-19 pandemic: guidance for nuclear medicine departments.

Paez D, Gnanasegaran G, Fanti S, Bomanji J, Hacker M, Sathekge M, Bom HS, Cerci JJ, Chiti A, Herrmann K, Scott AM, Czernin J, El-Haj N, Estrada E, Pellet O, Orellana P, Giammarile F, Abdel-Wahab M.

Eur J Nucl Med Mol Imaging. 2020 Jul;47(7):1615-1619. doi: 10.1007/s00259-020-04825-8.

PMID: 32296886Free PMC article.No abstract available.

35.

Letter from the Editors.

Bouchelouche K, Sathekge MM.

Semin Nucl Med. 2020 May;50(3):193-194. doi: 10.1053/j.semnuclmed.2020.03.002. Epub 2020 Mar 18.

PMID: 32284105No abstract available.

36.

PSMA expression on neovasculature of solid tumors.

Van de Wiele C, Sathekge M, de Spiegeleer B, De Jonghe PJ, Debruyne PR, Borms M, Beels L, Maes A.

Histol Histopathol. 2020 Sep;35(9):919-927. doi: 10.14670/HH-18-215. Epub 2020 Apr 13.

PMID: 32282924Review.

37.

Nuclear Medicine Operations in the Times of COVID-19: Strategies, Precautions, and Experiences.

Czernin J, Fanti S, Meyer PT, Allen-Auerbach M, Hacker M, Sathekge M, Hicks R, Scott AM, Hatazawa J, Yun M, Schöder H, Bartenstein P, Herrmann K.

J Nucl Med. 2020 May;61(5):626-629. doi: 10.2967/jnumed.120.245738. Epub 2020 Apr 1.

PMID: 32238430No abstract available.

38.

Letter from the Editors.

Sathekge MM, Bouchelouche K.

Semin Nucl Med. 2020 Mar;50(2):115-117. doi: 10.1053/j.semnuclmed.2020.02.014.

PMID: 32172794No abstract available.

39.

68Ga-PSMA: a One-stop Shop in Radioactive Iodine Refractory Thyroid Cancer?

Lengana T, Lawal IO, Mokoala K, Vorster M, Sathekge MM.

Nucl Med Mol Imaging. 2019 Dec;53(6):442-445. doi: 10.1007/s13139-019-00621-x. Epub 2019 Nov 11.

PMID: 31867081Free PMC article.

40.

Letter From the Editors.

Sathekge MM, Bouchelouche K.

Semin Nucl Med. 2020 Jan;50(1):1-4. doi: 10.1053/j.semnuclmed.2019.10.004. Epub 2019 Nov 11.

PMID: 31843057No abstract available.

41.

PET/CT features of extrapulmonary tuberculosis at first clinical presentation: a cross-sectional observational 18F-FDG imaging study across six countries.

Bomanji J, Sharma R, Mittal BR, Gambhir S, Qureshy A, Begum SMF, Paez D, Sathekge M, Vorster M, Sobic Saranovic D, Pusuwan P, Mann V, Vinjamuri S, Zumla A, Pascual TNB; International Atomic Energy Agency Extra-pulmonary TB Consortium.

Eur Respir J. 2020 Feb 27;55(2):1901959. doi: 10.1183/13993003.01959-2019. Print 2020 Feb.

PMID: 31831584

42.

Prostate-specific membrane antigen-targeted endoradiotherapy in metastatic prostate cancer.

Lawal IO, Bruchertseifer F, Vorster M, Morgenstern A, Sathekge MM.

Curr Opin Urol. 2020 Jan;30(1):98-105. doi: 10.1097/MOU.0000000000000685.

PMID: 31644433Review.

43.

18F-FDG PET/CT as a Noninvasive Biomarker for Assessing Adequacy of Treatment and Predicting Relapse in Patients Treated for Pulmonary Tuberculosis.

Lawal IO, Fourie BP, Mathebula M, Moagi I, Lengana T, Moeketsi N, Nchabeleng M, Hatherill M, Sathekge MM.

J Nucl Med. 2020 Mar;61(3):412-417. doi: 10.2967/jnumed.119.233783. Epub 2019 Aug 26.

PMID: 31451489

44.

Predictors of Overall and Disease-Free Survival in Metastatic Castration-Resistant Prostate Cancer Patients Receiving 225Ac-PSMA-617 Radioligand Therapy.

Sathekge M, Bruchertseifer F, Vorster M, Lawal IO, Knoesen O, Mahapane J, Davis C, Reyneke F, Maes A, Kratochwil C, Lengana T, Giesel FL, Van de Wiele C, Morgenstern A.

J Nucl Med. 2020 Jan;61(1):62-69. doi: 10.2967/jnumed.119.229229. Epub 2019 May 17.

PMID: 31101746